Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Myth-buster

Vitamin D supplementation was linked to a 50-point drop in a measure of beta-cell function in type 2 diabetes — but the same meta-analysis found it improved insulin, HbA1c, and inflammation.

This is one of the first meta-analyses to report a harmful effect on HOMA-B alongside clear benefits on other markers, so the picture is now genuinely contested — not settled.

HOMA-B reflects how well the pancreas's beta cells produce insulin in response to blood sugar. A drop of 50 points suggests worse beta-cell function, yet the same analysis found vitamin D lowered blood sugar, insulin resistance, and inflammation. Because the study didn't specify the dose or duration, and the HOMA-B result contradicts the overall pattern, this finding raises more questions than it answers.

Where this fits in the evidence

This is among the first studies we've indexed on Vitamin D for Reduced HOMA-B — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top